E
Jasper Therapeutics, Inc. JSPR
$2.92 -$0.04-1.35% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 22.47M 21.29M 20.42M 18.80M 17.88M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 94.05M 82.97M 76.24M 68.68M 68.15M
Operating Income -94.05M -82.97M -76.24M -68.68M -68.15M
Income Before Tax -90.92M -78.78M -71.27M -63.53M -62.44M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -90.92 -78.78 -71.27 -63.53 -62.44
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -90.92M -78.78M -71.27M -63.53M -62.44M
EBIT -94.05M -82.97M -76.24M -68.68M -68.15M
EBITDA -92.73M -81.61M -74.87M -67.27M -67.01M
EPS Basic -6.02 -5.25 -4.87 -4.75 -5.10
Normalized Basic EPS -3.76 -3.28 -3.04 -2.97 -3.21
EPS Diluted -6.02 -5.25 -4.87 -4.75 -5.10
Normalized Diluted EPS -3.76 -3.28 -3.04 -2.97 -3.21
Average Basic Shares Outstanding 60.37M 60.02M 58.33M 54.37M 50.34M
Average Diluted Shares Outstanding 60.37M 60.02M 58.33M 54.37M 50.34M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --